SOCS3/phosphorylated JAK2/phosphorylated STAT3 could suppress DCs-mediated anti-tumour T cell responses [199], while silencing IL-23R-STAT3 or activating STAT5 could maintain TFR cell stability [178]. The gene discussed is STAT3; the disease is neoplasm.